Mechanism study on anti-proliferative effects of curcumol in human hepatocarcinoma HepG2 cells

Zhongguo Zhongyao Zazhi

Volumn 38, Issue 11, 2013, Pages 1812-1815

  Huang, Lan Zhen ^a   Wang, Juan ^a   Lu, Fei Ting ^a   Yang, Fei Cheng ^a   Chen, Xu ^a   Hong, Xue ^a   Jiang, Xiao Shan ^a  

^a GUILIN MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle arrest; Curcumol; Hepatocarcinoma; Tumor cell proliferation

Indexed keywords

CHINESE DRUG; PSORALIDIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; BONE DENSITY; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; LOW DRUG DOSE; LUMBAR VERTEBRA; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; RAT; SHAM PROCEDURE; THIGH;

CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; SESQUITERPENES;

EID: 84881659309     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20131132     Document Type: Article

References (10)

1. 2009, 15(22): 3483.
2. 2011, 17(19): 157.
3. Sclafani R A, Holzen T M. Cell cycle regulation of DNA replication[J]. Annu Rev Genet, 2007, 41: 237.
4. Park M T, Lee S J. Cell cycle and cancer[J]. J Biochem Mol Biol, 2003, 36(1): 60.
5. 2009, 11 (4): 13.
6. 2011, 27(5): 493.
7. 1/S cell cycle progression in somatic cells[J]. Oncogene, 2005, 24(16): 2739.
8. Bäumer N, Tickenbrock L, Tschanter P, et al. Inhibitor of cyclin-dependent kinase (CDK) interacting with cyclin A1 (INCA1) regulates proliferation and is repressed by oncogenic signaling[J]. J Biol Chem, 2011, 286(32): 28210.
9. Donner A J, Szostek S, Hoover J M, et al. CDK8 is a stimulus-specific positive coregulator of p53 target genes[J]. Mol Cell, 2007, 27(1): 121.
10. Abukhdeir A M, Park B H. p21 and p27: roles in carcinogenesis and drug resistance[J]. Expert Rev Mol Med, 2008, 10: e19.